Le Chevalier T - Search Results

1

Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.

Erman M, Moretti L, Soria JC, Le Chevalier T, Van Houtte P. Erman M, et al. Among authors: le chevalier t. Semin Radiat Oncol. 2004 Oct;14(4):315-21. doi: 10.1016/j.semradonc.2004.07.005. Semin Radiat Oncol. 2004. PMID: 15558506 Review.

2

[Inappropriate antidiuretic hormone secretion disclosing a second primary lung cancer 5 years after complete remission of a small cell lung carcinoma].

Soria JC, Fizazi K, Merad M, Le Chevalier T. Soria JC, et al. Among authors: le chevalier t. Bull Cancer. 1996 Aug;83(8):605-8. Bull Cancer. 1996. PMID: 8869039 French.

3

Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.

Le Chevalier T, Brisgand D, Soria JC, Douillard JY, Pujol JL, Ruffie P, Aberola V, Cigolari S. Le Chevalier T, et al. Oncologist. 2001;6 Suppl 1:8-11. doi: 10.1634/theoncologist.6-suppl_1-8. Oncologist. 2001. PMID: 11181998 Free article. Clinical Trial.

4

Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

Soria JC, Brisgand D, Le Chevalier T. Soria JC, et al. Among authors: le chevalier t. Ann Oncol. 2001 Dec;12(12):1667-70. doi: 10.1023/a:1013574413217. Ann Oncol. 2001. PMID: 11843242 Free article. Clinical Trial.

5

[Therapeutic implications of epidermal growth factor receptor in lung cancer].

Fayette J, Le Chevalier T, Soria JC. Fayette J, et al. Among authors: le chevalier t. Bull Cancer. 2003 Nov;90 Spec No:S233-40. Bull Cancer. 2003. PMID: 14763145 Review. French.

6

[Adjuvant chemotherapy in non-small cell lung cancer].

Taillade L, Soria JC, André F, Grunenwald D, Dunant A, Pignon JP, Le Chevalier T. Taillade L, et al. Among authors: le chevalier t. Bull Cancer. 2004 Jan;91(1):63-7. Bull Cancer. 2004. PMID: 14975806 Free article. Review. French.

7

Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis.

Delbaldo C, Michiels S, Syz N, Soria JC, Le Chevalier T, Pignon JP. Delbaldo C, et al. Among authors: le chevalier t. JAMA. 2004 Jul 28;292(4):470-84. doi: 10.1001/jama.292.4.470. JAMA. 2004. PMID: 15280345

8

Adjuvant chemotherapy in early-stage non-small cell lung cancer.

Dômont J, Soria JC, Le Chevalier T. Dômont J, et al. Among authors: le chevalier t. Semin Oncol. 2005 Jun;32(3):279-83. doi: 10.1053/j.seminoncol.2005.02.018. Semin Oncol. 2005. PMID: 15988682 Review.

9

MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer.

Kamal NS, Soria JC, Mendiboure J, Planchard D, Olaussen KA, Rousseau V, Popper H, Pirker R, Bertrand P, Dunant A, Le Chevalier T, Filipits M, Fouret P; International Adjuvant Lung Trial-Bio investigators. Kamal NS, et al. Among authors: le chevalier t. Clin Cancer Res. 2010 Feb 15;16(4):1206-15. doi: 10.1158/1078-0432.CCR-09-2204. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145178

10

WITHDRAWN: Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.

Delbaldo C, Michiels S, Rolland E, Syz N, Soria JC, Le Chevalier T, Pignon JP. Delbaldo C, et al. Among authors: le chevalier t. Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD004569. doi: 10.1002/14651858.CD004569.pub3. Cochrane Database Syst Rev. 2012. PMID: 22513924 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters